Symbols

AVTR

Avantor·NYSE

--(--)

AVTR fundamentals

AVTR Q4 2025 Earnings

Avantor (AVTR) released its earnings on Feb 11, 2026: revenue was 1.66B (YoY -1.36%), beat estimates; EPS was 0.22 (YoY -18.52%), beat estimates.

Revenue / YoY

1.66B

-1.36%

EPS / YoY

0.22

-18.52%

Report date

Feb 11, 2026

AVTR Earnings Call Summary for Q4,2025

2026 Transition Year: Organic revenue growth -2.5% to -0.5%, adjusted EPS $0.77-$0.83.
Investments: $35M in e-commerce and operations, self-funded through cost savings.
Segment Focus: VWR expected to outpace Bioscience and Medtech Products due to challenging comps.
End Market Outlook: Biopharma stable, cautious on education/government sectors.
Free Cash Flow: Target $500-550M, prioritizing debt reduction.

Earnings

EPS

Revenue

Revenue & Expenses

AVTR has released its 2025 Q4 earnings report, with revenue of 1.66B, reflecting a YoY change of -1.36%, and net profit of 52.40M, showing a YoY change of -89.53%. The Sankey diagram below clearly presents AVTR's revenue sources and cost distribution.

Key Indicators

Avantor (AVTR) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Avantor (AVTR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Avantor (AVTR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Avantor (AVTR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown